srb-7 Antibody

What is Srb7 and what role does it play in cellular function?

Srb7 is a protein that plays a crucial role in transcription regulation within mammalian cells. It functions as a key component of high molecular weight coactivating complexes that facilitate communication between transcriptional activators and RNA polymerase II. Srb7 is part of the SMCC (SRB and MED protein cofactor complex), which is essential for enhancing gene-specific activation or repression by DNA-binding transcription factors. This complex includes other important proteins such as Med6 and Med7, which interact with coactivator proteins from the TRAP and DRIP complexes to promote steroid receptor-dependent transcriptional activation. SMCC association with PC4 (positive cofactor 4) allows for basal transcription repression independently of RNA polymerase II activity, highlighting Srb7's multifaceted role in gene regulation .

What applications is Srb7 antibody suitable for?

Srb7 Antibody (31-C) has been validated for multiple experimental applications including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), and enzyme-linked immunosorbent assay (ELISA). This versatility makes it an invaluable tool for researchers studying transcriptional mechanisms in various experimental contexts . When selecting an application, researchers should consider the specific experimental question and available sample types. For studies involving protein localization, IF is optimal, while protein-protein interaction studies would benefit from IP approaches.

What species reactivity does Srb7 antibody demonstrate?

The Srb7 Antibody (31-C) detects Srb7 protein of mouse, rat, and human origin, making it a versatile tool for comparative studies across different mammalian models . This cross-species reactivity reflects the high conservation of Srb7 protein sequence and function across species, which is consistent with its essential role in transcriptional regulation. The murine Srb7 gene shows significant homology to its yeast and human counterparts, indicating evolutionary conservation of this transcriptional regulatory component .

How should researchers optimize western blotting protocols for Srb7 detection?

For optimal western blot detection of Srb7, researchers should:

• Use nuclear extracts: Given Srb7's nuclear localization, enriched nuclear preparations yield better results than whole cell lysates.

• Sample preparation: Include protease inhibitors to prevent degradation, as Srb7 is part of large protein complexes.

• Gel selection: 10-12% SDS-PAGE gels typically provide optimal resolution for Srb7.

• Transfer conditions: Semi-dry transfer at lower voltage for longer duration is recommended.

• Blocking: 5% non-fat dry milk in TBST is typically sufficient.

• Primary antibody dilution: Begin with 1:1000 dilution of Srb7 Antibody (31-C) and optimize as needed.

• Incubation: Overnight incubation at 4°C often yields better results than shorter room temperature incubations.

• Detection: Enhanced chemiluminescence (ECL) systems provide good sensitivity for Srb7 detection .

When troubleshooting, verify antibody specificity through positive and negative controls, and consider that Srb7 is tightly associated with high molecular weight forms of RNA polymerase II, which may affect band patterns .

What controls are essential when performing immunofluorescence with Srb7 antibody?

When conducting immunofluorescence experiments with Srb7 Antibody, several controls should be included:

• Primary antibody omission: To assess non-specific binding of the secondary antibody.

• Isotype control: Using an irrelevant mouse IgG1 kappa antibody to evaluate non-specific binding.

• Blocking peptide competition: Pre-incubation of the antibody with excess Srb7 peptide should abolish specific staining.

• Positive control: Samples known to express Srb7 (most mammalian cell lines, given ubiquitous expression).

• Negative control: Samples with Srb7 knockdown, if available.

• Subcellular marker co-staining: Nuclear markers (DAPI) should co-localize with Srb7 staining.

• Cross-species validation: Similar staining patterns should be observed across mouse, rat, and human samples due to Srb7's conservation .

How can researchers validate the specificity of Srb7 antibody in their experimental system?

To validate Srb7 antibody specificity, researchers should employ multiple approaches:

• siRNA/shRNA knockdown: Reduced signal following Srb7 knockdown confirms specificity.

• Western blot analysis: A single band at the expected molecular weight supports specificity.

• Mass spectrometry: Immunoprecipitation followed by mass spectrometry should identify Srb7 as the predominant protein.

• Multiple antibodies: Using antibodies recognizing different epitopes of Srb7 should yield similar results.

• Recombinant protein: Testing against purified recombinant Srb7 protein can confirm direct binding.

• Cross-species reactivity: Consistent results across mouse, rat, and human samples provide additional validation .

How can Srb7 antibody be used to study transcriptional regulation mechanisms?

For investigating transcriptional regulation mechanisms, Srb7 antibody enables several sophisticated approaches:

• Chromatin Immunoprecipitation (ChIP): To identify genomic regions where Srb7-containing complexes bind.

  • Protocol: Crosslink protein-DNA complexes, sonicate chromatin, immunoprecipitate with Srb7 antibody, reverse crosslinks, and analyze DNA by qPCR or sequencing.

  • Critical parameters: Crosslinking time, sonication conditions, antibody concentration.

• Co-Immunoprecipitation (Co-IP): To identify novel protein interactions within transcriptional complexes.

  • Protocol: Prepare nuclear extracts, immunoprecipitate with Srb7 antibody, wash stringently, elute, and analyze by western blot or mass spectrometry.

  • Key consideration: Buffer composition can significantly affect complex stability.

• Proximity Ligation Assay (PLA): To visualize Srb7 interactions in situ.

  • Advantage: Provides spatial information about protein-protein interactions at endogenous levels.

• Immunofluorescence combined with transcription site visualization:

  • Approach: Co-stain for Srb7 and nascent RNA to correlate Srb7 localization with active transcription sites .

What approaches can elucidate Srb7's role in embryonic development?

Based on research findings that Srb7 is essential for cell viability and murine embryonic development, several experimental approaches can be employed:

• Conditional knockout models: Since complete Srb7 knockout is embryonically lethal, tissue-specific knockouts using Cre-loxP systems can reveal its function in specific developmental contexts.

• Embryoid body differentiation: Using embryonic stem cells with inducible Srb7 knockdown to form embryoid bodies can reveal its role in early lineage commitment.

• ChIP-seq during development: Profiling Srb7 binding sites across different developmental stages can identify stage-specific target genes.

• RNA-seq following Srb7 depletion in developmental models to identify gene networks under its regulation.

• Rescue experiments: Complementing Srb7-deficient cells with wild-type or mutant variants can define functionally critical domains .

How can one investigate Srb7's association with RNA polymerase II complexes?

To study Srb7's association with RNA polymerase II complexes:

• Size exclusion chromatography followed by western blotting:

  • Method: Fractionate nuclear extracts, analyze fractions by western blot using Srb7 antibody and RNA polymerase II antibodies.

  • Expected results: Srb7 co-elutes with high molecular weight forms of RNA polymerase II .

• Density gradient centrifugation:

  • Approach: Separate protein complexes by density, analyze fractions for Srb7 and RNA polymerase II components.

  • Advantage: Provides information about the size and composition of native complexes.

• Mass spectrometry following Srb7 immunoprecipitation:

  • Method: Immunoprecipitate with Srb7 antibody, digest proteins, and analyze by LC-MS/MS.

  • Output: Comprehensive list of associated proteins, including RNA polymerase II subunits and other mediator components.

• Sequential immunoprecipitation:

  • Approach: First immunoprecipitate with RNA polymerase II antibody, then re-immunoprecipitate with Srb7 antibody.

  • Purpose: Confirms direct association within the same complexes .

What are common causes of weak or no signal when using Srb7 antibody in western blotting?

When troubleshooting weak or absent Srb7 signals in western blotting:

• Sample preparation issues:

  • Insufficient nuclear extraction (Srb7 is primarily nuclear)

  • Protein degradation during sample handling

  • Inadequate protein loading amount

• Technical parameters:

  • Suboptimal primary antibody concentration (try 1:500 - 1:2000 range)

  • Insufficient incubation time (overnight at 4°C recommended)

  • Inefficient protein transfer to membrane

• Buffer composition problems:

  • Incorrect pH of buffers affecting epitope recognition

  • Incompatible detergents in sample buffer

  • Absence of phosphatase or protease inhibitors

• Detection system limitations:

  • Low sensitivity of detection method for low-abundance proteins

  • Expired ECL reagents

  • Insufficient exposure time .

How should researchers address non-specific binding in immunofluorescence experiments?

To minimize non-specific binding in immunofluorescence:

• Optimize blocking conditions:

  • Try different blocking agents (BSA, normal serum, commercial blockers)

  • Increase blocking time (1-2 hours at room temperature)

  • Add 0.1-0.3% Triton X-100 to blocking solution

• Antibody dilution optimization:

  • Titrate Srb7 antibody concentrations (start with 1:100-1:500)

  • Increase wash steps duration and number

  • Pre-absorb antibody with tissue powder from species of interest

• Secondary antibody considerations:

  • Use highly cross-adsorbed secondary antibodies

  • Minimize cross-reactivity by selecting appropriate isotype-specific secondaries

  • Filter secondary antibodies to remove aggregates

• Tissue/cell preparation:

  • Optimize fixation protocol for epitope preservation

  • Consider antigen retrieval methods

  • Reduce autofluorescence using sodium borohydride or commercial reagents .

What factors affect Srb7 antibody performance in co-immunoprecipitation experiments?

Several factors can impact Srb7 antibody performance in co-immunoprecipitation:

• Buffer composition:

  • Salt concentration: High salt (>300mM) may disrupt protein-protein interactions

  • Detergent type: Gentle detergents (0.1% NP-40 or Triton X-100) preserve complexes

  • pH: Optimal range (7.0-8.0) is crucial for antibody-antigen binding

• Antibody characteristics:

  • Epitope accessibility: The Srb7 epitope may be masked in certain protein complexes

  • Antibody affinity: Higher affinity antibodies perform better in IP applications

• Experimental conditions:

  • Cross-linking may be necessary to capture transient interactions

  • Incubation time: Longer incubations (4-16 hours) often improve complex precipitation

  • Temperature: Conducting IP at 4°C helps preserve protein complexes

• Bead selection:

  • Pre-clearing samples reduces non-specific binding

  • Protein A vs. Protein G beads have different affinities for mouse IgG1 antibodies .

How can Srb7 antibody be used in ChIP-seq experiments to investigate global transcriptional regulation?

For ChIP-seq experiments with Srb7 antibody:

• Sample preparation protocol:

  • Crosslink protein-DNA complexes with 1% formaldehyde (10 minutes)

  • Quench with 125mM glycine

  • Isolate nuclei and sonicate to generate 200-500bp DNA fragments

• Immunoprecipitation approach:

  • Pre-clear chromatin with Protein G beads

  • Incubate chromatin with Srb7 antibody (5-10μg) overnight at 4°C

  • Include IgG isotype control for background assessment

  • Use positive controls (antibodies against RNA Pol II)

• Data analysis considerations:

  • Align sequences to reference genome

  • Call peaks to identify Srb7 binding sites

  • Perform motif analysis to identify associated transcription factors

  • Integrate with gene expression data to correlate binding with transcriptional outcomes .

What recent technological advances have enhanced the applications of Srb7 antibody in research?

Recent technological advances expanding Srb7 antibody applications include:

• Single-cell techniques:

  • Single-cell ChIP-seq for mapping Srb7 binding in individual cells

  • Single-cell immunofluorescence with high-content imaging

  • Integration with single-cell transcriptomics to reveal cell-type-specific Srb7 regulatory networks

• Proximity labeling approaches:

  • BioID or APEX2 fusion with Srb7 to identify transient interacting partners

  • Validation of proximity labeling results using Srb7 antibody

• Super-resolution microscopy:

  • STORM, PALM, and STED provide nanoscale resolution of Srb7 localization

  • Multi-color super-resolution enables visualization of Srb7 co-localization with other transcriptional components

• CUT&RUN and CUT&TAG:

  • Higher resolution alternatives to traditional ChIP approaches

  • Require less starting material and offer improved signal-to-noise ratio .

What is the significance of Srb7's evolutionary conservation for comparative studies?

The high conservation of Srb7 across species offers unique research opportunities:

• Evolutionary implications:

  • Conservation from yeast to humans indicates fundamental importance in eukaryotic transcription

  • Mouse Srb7 gene is single copy and expressed in all tissues examined, suggesting universal function

  • Disruption of Srb7 is lethal in embryonic development, confirming its essential role

• Comparative experimental approaches:

  • Cross-species antibody reactivity allows direct comparison of mechanisms across model organisms

  • Functional complementation studies between species can identify conserved domains

  • Evolutionary rate analysis can identify functional constraints on protein sequence

• Translational significance:

  • Findings in model organisms likely translate to human biology due to conservation

  • Cross-species conservation facilitates the development of broad-spectrum tools for research

  • Understanding conserved mechanisms provides insight into fundamental aspects of transcriptional regulation .